Misty J. Eaton

Misty J. Eaton


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
TWTorsten Weiss
Torsten Weiss
RBRené Bernard
René Bernard
GLGregor Laube
Gregor Laube
JRJulian Engelbert Emil Rieck
Julian Engelbert Emil Rieck
MEMisty J. Eaton
Misty J. Eaton
RVRüdiger W. Veh
Rüdiger W. Veh
The importance of polyamines (PAs) for the central nervous system (CNS) is well known. Less clear, however, is where PAs in the brain are derived from. Principally, there are three possibilities: (i) intake by nutrition, release into the bloodstream, and subsequent uptake from CNS capillaries, (ii) production by parenchymatous organs, such as the liver, and again uptake from CNS capillaries, and (iii) uptake of precursors, such as arginine, from the blood and subsequent local biosynthesis of PAs within the CNS. The present investigation aimed to unequivocally answer the question of whether PAs, especially the higher ones like spermidine (SPD) and spermine (SPM), can or cannot be taken up into the brain from the bloodstream. For this purpose, a biotin-labelled analogue of spermine (B-X-SPM) was synthesized, characterized, and used to visualize its uptake into brain cells following application to acute brain slices, to the intraventricular space, or to the bloodstream. In acute brain slices there is strong uptake of B-X-SPM into protoplasmic and none in fibrous-type astrocytes. It is also taken up by neurons but to a lesser degree. Under in vivo conditions, astrocyte uptake of B-X-SPM from the brain interstitial fluid is also intense after intraventricular application. In contrast, following intracardial injection, there is no uptake from the bloodstream, indicating that the brain is completely dependent on the local synthesis of polyamines.

1 February 2014 in Journal of Neuroscience and Neuroengineering
Verified
Journal Article
Closed access
LKLilia Kucheryavykh
Lilia Kucheryavykh
KRKimberleve Rolón-Reyes
Kimberleve Rolón-Reyes
YKYuriy Kucheryavykh
Yuriy Kucheryavykh
SSSerguei Skatchkov
Serguei Skatchkov
MEMisty J. Eaton
Misty J. Eaton
Mikhail InyushinMikhail Inyushin
Mikhail Inyushin
Organic cation transporters (OCTs) were first found and then isolated from cultured glioma cells. When glioma cells are implanted into brain the fate of OCTs varies with time after implantation and transporter type. Here we report that OCT1, OCT2 and OCT3 immunofluorescence is significantly reduced over time in implanted GL261 glioma cells, during tumor development in the brain. By day 21 after glioma implantation, OCT1, OCT2 and OCT3 immunofluorescence was reduced more than 10-fold in the cytoplasm of glioma cells, while OCT3 immunofluorescence became concentrated in the nucleus. The well-known fluorescent substrate for OCT transporters, 4-(4-(dimethylamino)-styryl)-N-methylpyridinium iodide (ASP+), previously shown to accumulate in glioma-cell cytoplasm in in vivo slices, began to accumulate in the nucleus of these cells, but not in cytoplasm, after 21 days post-implantation. Considering this mislocalization phenomenon, and other literature on similar nuclear mislocalization of different transporters, receptors and channels in glioma cells, we suggest that it is one of the “omens” preceding the motility and aggressivity changes in glioma behavior.

1 February 2015 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
AHAdriana Huertas
Adriana Huertas
WWWilliam D. Wessinger
William D. Wessinger
YKYuriy Kucheryavykh
Yuriy Kucheryavykh
PSPriscila Sanabria
Priscila Sanabria
MEMisty J. Eaton
Misty J. Eaton
Mikhail InyushinMikhail Inyushin
Mikhail Inyushin

23 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
TWTorsten Weiss
Torsten Weiss
RBRené Bernard
René Bernard
GLGregor Laube
Gregor Laube
JRJulian Engelbert Emil Rieck
Julian Engelbert Emil Rieck
MEMisty J. Eaton
Misty J. Eaton
RVRüdiger W. Veh
Rüdiger W. Veh
The importance of PAs for CNS functions are well known. Less clear is, however, where PAs in the brain are derived from. Principally, there are three possibilities: (i) intake by nutrition, release into the bloodstream, and subsequent uptake from CNS capillaries, (ii) products of parenchymatous organs as the liver, and again uptake from CNS capillaries, and (iii) uptake of precursors such as arginine from the blood and subsequent local biosynthesis of polyamines within the CNS.The present investigation aimed to unequivocally answer the question, whether PAs, especially the higher ones like SPD and SPM can or cannot be taken up into the brain from the bloodstream. For this purpose a biotin-labelled analogue of SPM was synthesized, characterized, and used to visualize its uptake into brain cells subsequent to application to surviving brain slices, to the intraventricular space, or to the bloodstream.In surviving slices uptake of B-X-SPM is massive into protoplasmic and absent in fibrous type astrocytes. It is also taken up by neurons but to a lesser degree. Under in-vivo conditions astrocyte uptake of biotinylated SPM also is massive from the brain interstitial fluid subsequent to intraventricular application. In contrast, following intracardial injection there is no uptake from the bloodstream, indicating that the brain is completely dependent on the local synthesis of polyamines.